- TNFA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
TNF Pharmaceuticals (TNFA) 10-K/A2017 FY Annual report (amended)
Filed: 13 Jul 18, 4:23pm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Amendment to No. 1 to Form S-3 dated November 15, 2016 of Akers Biosciences, Inc. and the related Prospectus included therein, of our report dated April 2, 2018, relating to our audit of the consolidated financial statements of Akers Biosciences, Inc. appearing in the Company’s Annual Report on Form 10-K/A of Akers Biosciences, Inc. for the year ended December 31, 2017.
/s/ Morison Cogen LLP
Blue Bell, Pennsylvania
July 13, 2018
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.